Zygomycosis in a 13 year old girl with T-NHL.
We report the clinical and pathological findings of an unusual invasive fungal infection in a 13-year-old girl with T-NHL. The diagnosis of disseminated Zygomycosis was made four days after onset of clinical symptoms. Risk factors for Zygomycosis were prolonged neutropenia, corticosteroids, and steroid induced diabetes mellitus.
Kollmar
N
N
University Medicine Göttingen, Department of Pediatrics I Hematology/Oncology, Göttingen, Germany. nina.jendreyko@med.uni-goettingen.de
Lakomek
M
M
Kühnle
I
I
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects; D001706:Biopsy; D001921:Brain / Q000473:pathology; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008279:Magnetic Resonance Imaging; D009091:Mucormycosis / Q000175:diagnosis* / Q000473:pathology; D009336:Necrosis; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012867:Skin / Q000473:pathology; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin